Tenofovir (TDF) for chronic hepatitis B patients with suboptimal response to adefovir (ADV) or ADV/LAM treatment: results of the OPTIB Italian Multicenter prospective open label study

Levrero, M.;Cimino, L.;Lampertico, P.;Viganò, M.;Gaeta, G.b.;Brancaccio, G.;Sagnelli, E.;Messina, V.;Raimondo, G.;Marzano, A.;Fagiouli, S.;Niro, G.a.;SANTANTONIO, TERESA ANTONIA;Di Marco, V.;Mazzella, G.;Di Costanzo, G.g.;Angelico, M.;Pierconti, S.;Savà, C.c.

2010-01-01